• Biomarker Tests

    Home-based test to predict flare-ups in chest infections

    A natural extension of our philosophy of self-management through self-monitoring is the Company’s development of a home-based test to predict flare-ups in chest infections (in people of all ages) who have long-term respiratory conditions, to reduce hospital admissions and improve healthcare. Our system is ideally suited for those with long-term conditions such as: Asthma, Chronic Obstructive Pulmonary Disease (COPD or emphysema), Cystic Fibrosis (CF) and non-CF Bronchiectasis (NCFB).

Sign up to our Newsletter